title: Ovomucoid (Gal d 1) specific IgE detected by microarray system predict tolerability to boiled hen's egg and an increased risk to progress to multiple environmental allergen sensitisation.
abstract: BACKGROUND
  Egg allergy is a very common finding in early childhood. Detecting hen's egg (HE) allergy outgrowing and reintroduction of food containing egg is a task for the allergist.
  
  
  OBJECTIVE
  We sought to evaluate the suitability of boiled egg food challenge compared with IgE to allergenic molecules from HE white using a microarray system.
  
  
  METHODS
  Sixty-eight children referring to our centre by the family paediatricians for a suspected egg allergy were enrolled. Patients underwent double-blind, placebo-controlled food challenge with boiled and raw eggs. Challenge outcomes were compared with skin tests performed using egg white and yolk commercial extracts, to prick-prick test with boiled and raw egg white and yolk, total IgE, egg white specific IgE detected using ImmunoCAP and IgE to egg allergens available on the immunosolid phase allergen chip (ISAC) 103 microarray.
  
  
  RESULTS
  Nineteen subjects (28%) were reactive to both raw and boiled egg, 14 (20.5%) to raw egg only and 35 (51.4%) tolerated both boiled and raw egg. Efficiency analysis was carried out using both raw and boiled egg challenges as gold standard. Forty four of 47 Gal d 1 negative patients tolerated boiled egg (94%). Conversely, 20 of 21 Gal d 1 positive patients reacted to raw egg (95%). None of the other tests was able to discriminate patients' response to HE challenge. Furthermore, Gal d 1 positivity seems to lead to broader environmental allergen IgE sensitization.
  
  
  CONCLUSIONS
  The Gal d 1 IgE reactivity appears to be a very good predictor of HE clinical allergy. Gal d 1 positive children have a high frequency of HE allergy, whereas Gal d 1 negative children have a high frequency of tolerance to boiled egg. Multiple specific IgE detection by means of ISAC improves the diagnostic approach in HE allergic children, disclosing other food and inhalant allergic sensitizations, anyhow requiring a comprehensive clinical evaluation.
authors.affiliation: Center for Molecular Allergology, IDI-IRCCS, Rome, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Alessandri
authors.forename: D
authors.initials: D
authors.lastname: Zennaro
authors.forename: E
authors.initials: E
authors.lastname: Scala
authors.forename: R
authors.initials: R
authors.lastname: Ferrara
authors.forename: M Livia
authors.initials: ML
authors.lastname: Bernardi
authors.forename: M
authors.initials: M
authors.lastname: Santoro
authors.forename: P
authors.initials: P
authors.lastname: Palazzo
authors.forename: A
authors.initials: A
authors.lastname: Mari
mesh_terms: D000284:Administration, Oral; D000485:Allergens / Q000008:administration & dosage / Q000276:immunology; D000818:Animals; D002645:Chickens; D002648:Child; D002675:Child, Preschool; D004311:Double-Blind Method; D021181:Egg Hypersensitivity / Q000175:diagnosis*; D005260:Female; D006801:Humans; D007118:Immunoassay; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology; D007159:Immunologic Tests / Q000379:methods*; D007223:Infant; D008297:Male; D010059:Ovomucin / Q000276:immunology*; D012307:Risk Factors; D012680:Sensitivity and Specificity
chemical_list: D000485:Allergens; D010059:Ovomucin; D007073:Immunoglobulin E